Paper34492005
The cardiovascular effects of amodiaquine and structurally related antimalarials: An individual patient data meta-analysis.
Chan XHS and 16 others. PLoS Med, 2021. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. The cardiovascular effects of amodiaquine and structurally related antimalarials: An individual patient data meta-analysis. Papers, record 34492005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34492005
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amodiaquine | Major topic |
| Antimalarials | Major topic |
| Bradycardia | Major topic |
| Heart Conduction System | Major topic |
| Heart Rate | Major topic |
| Long QT Syndrome | Major topic |
| Adolescent | |
| Adult | |
| Cardiotoxicity | |
| Child | |
| Child, Preschool | |
| Female | |
| Humans | |
| Infant | |
| Male | |
| Middle Aged | |
| Randomized Controlled Trials as Topic | |
| Risk Assessment | |
| Risk Factors | |
| Young Adult |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Wellcome Trust | United Kingdom | PubMed | ||
| MR/N013468/1 | Medical Research Council | United Kingdom | PubMed | |
| 107886/Z/15/Z | Wellcome Trust | United Kingdom | PubMed | |
| 106698/Z/14/Z | Wellcome Trust | United Kingdom | PubMed |
Source PubMed
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21709098 | Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malaria. | Antimicrob Agents Chemother | 2011 | https://conductscience.org/library/papers/21709098 | PubMed |
| 2 | 29606364 | Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial. | Lancet | 2018 | https://conductscience.org/library/papers/29606364 | PubMed |
| 3 | 33278936 | Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study. | Lancet | 2020 | https://conductscience.org/library/papers/33278936 | PubMed |
| 4 | 3878759 | The anticholinesterase activity of mefloquine. | Clin Exp Pharmacol Physiol | 1985 | https://conductscience.org/library/papers/3878759 | PubMed |
| 5 | 11791962 | Cardiac effects of amodiaquine and sulfadoxine-pyrimethamine in malaria-infected African patients. | Am J Trop Med Hyg | 2001 | https://conductscience.org/library/papers/11791962 | PubMed |
| 6 | 23591829 | Safety of Artemisinin-Based Combination Therapies in Nigeria: A Cohort Event Monitoring Study. | Drug Saf | 2013 | https://conductscience.org/library/papers/23591829 | PubMed |
| 7 | 2138674 | Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain. | J R Soc Med | 1990 | https://conductscience.org/library/papers/2138674 | PubMed |
| 8 | 28049523 | Safety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d'Ivoire. | Malar J | 2017 | https://conductscience.org/library/papers/28049523 | PubMed |
| 9 | 28722611 | Phase 2a, Open-Label, 4-Escalating-Dose, Randomized Multicenter Study Evaluating the Safety and Activity of Ferroquine (SSR97193) Plus Artesunate, versus Amodiaquine Plus Artesunate, in African Adult Men with Uncomplicated Plasmodium falciparum Malaria. | Am J Trop Med Hyg | 2017 | https://conductscience.org/library/papers/28722611 | PubMed |
| 10 | 32134952 | Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient data. | PLoS Med | 2020 | https://conductscience.org/library/papers/32134952 | PubMed |
| 11 | 19404632 | Tolerability and pharmacokinetics of non-fixed and fixed combinations of artesunate and amodiaquine in Malaysian healthy normal volunteers. | Eur J Clin Pharmacol | 2009 | https://conductscience.org/library/papers/19404632 | PubMed |
| 12 | 28556586 | Dihydroartemisinin-piperaquine versus artesunate-amodiaquine for treatment of malaria infection in pregnancy in Ghana: an open-label, randomised, non-inferiority trial. | Trop Med Int Health | 2017 | https://conductscience.org/library/papers/28556586 | PubMed |
| 13 | 18415093 | Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers. | Eur J Clin Pharmacol | 2008 | https://conductscience.org/library/papers/18415093 | PubMed |
| 14 | 14197832 | QUINIDINE SYNCOPE. PAROXYSMAL VENTRICULAR FIBRILLATION OCCURRING DURING TREATMENT OF CHRONIC ATRIAL ARRHYTHMIAS. | Circulation | 1964 | https://conductscience.org/library/papers/14197832 | PubMed |
| 15 | 20368402 | Population pharmacokinetics and pharmacodynamic considerations of amodiaquine and desethylamodiaquine in Kenyan adults with uncomplicated malaria receiving artesunate-amodiaquine combination therapy. | Antimicrob Agents Chemother | 2010 | https://conductscience.org/library/papers/20368402 | PubMed |
| 16 | 27764102 | Safety of Seasonal Malaria Chemoprevention (SMC) with Sulfadoxine-Pyrimethamine plus Amodiaquine when Delivered to Children under 10 Years of Age by District Health Services in Senegal: Results from a Stepped-Wedge Cluster Randomized Trial. | PLoS One | 2016 | https://conductscience.org/library/papers/27764102 | PubMed |
| 17 | 25515698 | Fixed dose artesunate amodiaquine - a phase IIb, randomized comparative trial with non-fixed artesunate amodiaquine. | Malar J | 2014 | https://conductscience.org/library/papers/25515698 | PubMed |
| 18 | 26660066 | Predicting drug-induced QT prolongation and torsades de pointes. | J Physiol | 2016 | https://conductscience.org/library/papers/26660066 | PubMed |
| 19 | 30038039 | Population Pharmacokinetics of the Antimalarial Amodiaquine: a Pooled Analysis To Optimize Dosing. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/30038039 | PubMed |
| 20 | 7256355 | Investigation of the anti-acetylcholinesterase activities of the antimalarial agent, amodiaquine, and related compounds. | Southeast Asian J Trop Med Public Health | 1981 | https://conductscience.org/library/papers/7256355 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41588921 | Amodiaquine Enhances Anti-Melanoma Efficacy of Attenuated Salmonella via Targeting Glutathione Reductase in Neutrophils. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41588921 | PubMed |
| 41568626 | Histamine N-methyltransferase upregulation, cardiac hypertrophy, and heart failure. | Eur Heart J | 2026 | https://conductscience.org/library/papers/41568626 | PubMed |
| 37735560 | Modeling policy interventions for slowing the spread of artemisinin-resistant pfkelch R561H mutations in Rwanda. | Nat Med | 2023 | https://conductscience.org/library/papers/37735560 | PubMed |
| 36256474 | Cardiovascular concentration-effect relationships of amodiaquine and its metabolite desethylamodiaquine: Clinical and preclinical studies. | Br J Clin Pharmacol | 2023 | https://conductscience.org/library/papers/36256474 | PubMed |
| 35209067 | Evaluation of Nutritional Substances and Investigation of Antioxidant and Antimicrobial Potentials of Boerhavia diffusa with in Silico Molecular Docking. | Molecules | 2022 | https://conductscience.org/library/papers/35209067 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ACHE | 43 | PubTator's text mining | https://conductscience.org/library/genes/43 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34492005
GET https://conductscience.org/api/papers/v1/34492005/references?page=2